Flavonoid-rich Albizia niopoides leaf extract shows anti-Trypanosoma cruzi activity against benznidazole-resistant parasites
Abstract
Chagas disease affects approximately 6–7 million people worldwide, with current treatments limited by toxicity and parasite resistance. This study evaluated ethanolic extracts from stems and leaves of three Brazilian Cerrado species ( Curatella americana , Nectandra nitidula , and Albizia niopoides ) against the benznidazole-resistant Trypanosoma cruzi Y strain (DTU II) in vitro. Cytotoxicity assessment in Vero cells revealed high toxicity for most extracts, with only A. niopoides leaves showing a favorable therapeutic window (CC 50 > 1600 µg/mL). Against epimastigotes, A. niopoides leaf extract exhibited the highest antiparasitic effect (IC 50 = 150.72 µg/mL) among plant extracts. This extract was selected for intracellular amastigote assays in H9c2 cardiomyocytes, achieving 85.9% inhibition at 400 µg/mL with an IC 50 of 150.72 µg/mL. The selectivity index was > 10.61 in Vero cells and 1.6 in H9c2 cells, remaining below the threshold of ≥ 50 recommended for drug development. UHPLC-MS analysis identified four flavonoids: rutin (50.2% relative abundance), isoquercitrin (7.5%), luteolin-7- O -rutinoside (1.9%), and 7- O -methyl- quercetin (25.3%) as potential chemical markers. These identifications were classified as Metabolomics Standards Initiative (MSI) Level 2 (rutin, isoquercitrin, and luteolin-7- O -rutinoside, confirmed against authentic standards) and Level 3 (7- O -methyl-quercetin, tentative). These findings identify flavonoid glycosides as potential chemical markers…
Read the paper
Related studies
- Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
- Challenges in Chagas Disease Drug Development
- T Cell Specificity: A Great Challenge in Chagas Disease
- Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice
- Rapid Molecular Detection of Terbinafine-resistant Dermatophytes
- Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.